Sai Life Sciences IPO
Sai Life Sciences IPO is listed on BSE and NSE, priced at ₹522–₹549 per share. The stock debuted at ₹650, delivering a listing gain of 18.4%. The IPO had a lot size of ₹27 shares and a minimum investment of ₹14,823.
Sai Life Sciences Limited IPO
- IPO Dates
- Dec 11, 2024 – Dec 13, 2024
- Price band
- ₹522-549 per equity share
- Minimum Investment
- ₹14,823
- Issue size
- ₹3042.62 Cr
- Lot size
- 27
- Allotment Date
- Dec 16, 2024
- Listing
- Dec 18, 2024
- Listing At
- BSE, NSE
IPO timeline
-
Dec 11, 2024
Open Date
Completed
-
Dec 13, 2024
Close Date
Completed
-
Dec 16, 2024
Allotment Date
Completed
-
Dec 18, 2024
Listing Date
Completed
Price Summary
- Last closing
- 1,132.00 (106.19%)
- 52 week high
- 1,184.80
- 52 week low
- 707.00
- Last update
Sai Life Sciences IPO Essentials
Sai Life Sciences IPO Details
Sai Life Sciences IPO is priced at ₹522-549 per share with a total issue size of 3042.62 crore. The IPO has a lot size of 27 shares and is listed on BSE and NSE.
- Issue price
- ₹522-549 per equity share
- Lot size
- 27 shares
- Face value
- ₹1 Per Equity Share
- Issue size
- Total ₹3,042.62 Cr :
#Fresh Issue : 17,304,189 shares(aggregating up to ₹950 Cr) +
#OFS : 38,116,934 shares of ₹1(aggregating up to ₹2,092.62 Cr) - Total issue size
- 5,54,21,123 shares
(aggregating up to ₹3042.62 crore) - Fresh issue
- 1,73,04,189 shares
(aggregating up to ₹950 crore) - Offer for sale (OFS)
- 3,81,16,934 shares
(aggregating up to ₹2092.62 crore) - Listing at
- BSE, NSE
- List price
- 650.0(NSE)
- Listing date
- Registrar
- Kfin Technologies Limited
- Lead manager
-
Kotak Mahindra Capital Company Limited, Jefferies India Private Limited, Morgan Stanley India Company Pvt Ltd, Iifl Securities Ltd
Market Lot Size
Investors can bid for a minimum of 27 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 27 | ₹14,823 |
| Retail(max) | 13 | 351 | ₹1,92,699 |
Sai Life Sciences IPO Reservation
Sai Life Sciences IPO reservation details show category-wise allocation of shares. Out of the total 5,54,21,121 shares, approximately 20% are reserved for QIB, 15% for NII, 35% for retail investors, and 30% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 1,66,26,336 (30%) | |
| QIB Shares Offered | 1,10,84,225 (20%) | |
| NII (HNI) Shares Offered | 83,13,168 (15%) | |
| bHNI > ₹10L | 55,42,113 (10%) | 14,661 |
| sHNI < ₹10L | 27,71,056 (5%) | 7,330 |
| Retail Shares Offered | 1,93,97,392 (35%) | 7,18,421 |
| Total Shares Offered | 5,54,21,121 (100%) |
Sai Life Sciences IPO Analytics
Sai Life Sciences IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Sai Life Sciences IPO Subscription Status
Sai Life Sciences IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 11,084,225 |
8,313,168
5,542,113
2,771,056
|
19,397,392 | 38,794,785 |
|
Day 1
11-12-24 05:00 PM
|
2.62 x |
0.15x
0.15x
0.17x
|
0.18 x | 0.84 x |
|
Day 2
12-12-24 05:00 PM
|
3.32 x |
0.59x
0.58x
0.62x
|
0.42 x | 1.25 x |
|
Day 3
13-12-24 05:00 PM
|
30.93 x |
4.92x
6.00x
2.74x
|
1.37 x | 10.26 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 6,46,482 (Approx) | —x | —x | 0.86x |
Sai Life Sciences Valuations
Earnings
- EPS Pre IPO
- 4.34
- EPS Post IPO
- 2.69
- P/E Pre IPO
- 126.42
- P/E Post IPO
- 203.82
Returns
- ROE
- 11.79%
- ROCE
- 15.96%
- RoNW
- 8.13%
- PAT Margin
- 5.65
Fundamentals
- Price / Book
- 10.18
Sai Life Sciences Financials( In Crs.)
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 2,275.14 | 2,186.65 | 2,164.23 |
| Revenue | 1,494.27 | 1,245.11 | 897.74 |
| Profit After Tax | 82.81 | 9.99 | 6.23 |
| Net Worth | 974.34 | 887.29 | 877.76 |
| Reserves & Surplus | 953.99 | 867.43 | 859.17 |
| Total Borrowing | 710.16 | 699.23 | 751.32 |
Sai Life Sciences Company & Offer Insights
About Sai Life Sciences
Headquartered in January 1999, Sai Life Sciences Limited is a leading pharmaceutical firm specializing in the research and development and manufacturing of small-molecule new chemical entities (NCEs). It collaborates with global biotech firms and pharmaceutical giants and delivers customized solutions across the drug discovery and development continuum.
In FY 2024, Sai Life Sciences serviced over 280 pharmaceutical innovators, including 18 of the top 25 global pharmaceutical companies by revenue (2023). The company supported more than 230 clients in its key markets, such as the US, UK, Europe, and Japan alone in September 2024.
Sai Life Sciences is different for being an integrated CRDMO, offering end-to-end solutions fully combining discovery, development, and manufacturing. Its CRO services give a solid stage for discovery, and in its CDMO, all scaling is done reliably to take on commercial and developmental work.
Sai Life Sciences Promoter(s)
Kanumuri Ranga Raju, Krishnam Raju Kanumuri, Kanumuri Mytrey, Sai Quest Syn Private Limited, Sunflower Partners, Lily Partners, Marigold Partners, Tulip Partners are the company's promoters of Sai Life Sciences.
Sai Life Sciences IPO Issue Objectives
- •
- Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company
- •
- General corporate purposes
Sai Life Sciences IPO - Anchor Investors
Sai Life Sciences mops up Rs 913 crore through anchor book.
Several marquee names in the anchor book including INQ Holdings, Smallcap World Fund, Fidelity, Blackrock, Abu Dhabi Investment Authority, Goldman Sachs, TIMF Holdings, Morgan Stanley, and Eastspring Investments.
HDFC Mutual Fund, Nippon Life India, Axis Mutual Fund, Kotak Mahindra AMC, Aditya Birla Sun Life AMC, DSP MF, Mirae Asset, SBI Life Insurance, UTI Mutual Fund, Whiteoak Capital, Bandhan Mutual Fund, Franklin, HSBC MF, Invesco, Max Life Insurance, Aditya Birla Sun Life Insurance, and Kotak Mahindra Life Insurance among domestic institutional investors also invested in the company.
Sai Life Sciences IPO - Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Sai Life Sciences Limited | 4.57 | 4.53 | 53.83 | N/A | 8.5 | N/A | Consolidated |
| DIVI'S LABORATORIES Limited | 60.27 | 60.27 | 511.21 | 103.04 | 11.79 | 6.72 | Consolidated |
| Suven Pharmaceuticals Limited | 11.8 | 11.8 | 94.04 | 109.37 | 14.64 | 7.2 | Consolidated |
| Syngene International Ltd | 12.71 | 12.69 | 105.91 | 73.59 | 11.98 | 6.69 | Consolidated |
Notes:
- Basic and diluted earnings per equity share are computed by Indian Accounting Standard 33 notified under the Companies (Indian Accounting Standards) Rules of 2015 (as amended).
- Net Asset Value per share = Restated equity attributable to owners of our Company / total number of equity shares outstanding during the period.
- Return on Net Worth (%) = Restated net profit/(loss) after tax for the years/period attributable to the owners of our Company / by the Net worth as on the last date of the respective period.
Sai Life Sciences IPO - Strengths and Risks
Sai Life Sciences IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Sai Life Sciences
+9140 6815 6000
Plot No. DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078
Registrar Contact Details
Frequently Asked Questions
Click any question to reveal the answer
Sai Life Sciences IPO is a book-built IPO worth ₹3042.62 crore. The price band is ₹522–₹549 per share. The IPO opens on Dec 11, 2024 and closes on Dec 13, 2024. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.
The price band of Sai Life Sciences IPO is ₹522 to ₹549 per share.
The lot size of Sai Life Sciences IPO is 27 shares.
The minimum investment for Sai Life Sciences IPO is approximately ₹14,823 based on the upper price band .
Sai Life Sciences IPO opens on Dec 11, 2024 and closes on Dec 13, 2024.
The allotment date of Sai Life Sciences IPO is Dec 16, 2024.
Sai Life Sciences IPO is expected to be listed on Dec 18, 2024, on BSE and NSE .
Sai Life Sciences IPO listed on Dec 18, 2024. It was issued at ₹650.0(NSE) and is currently around ₹1132.00 as on 27-May-2026 3:30 PM, which is approximately 106.2% versus issue price. The 52-week high is ₹1,184.80.
Based on listing and post-listing performance, Sai Life Sciences IPO delivered around 106.2% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Sai Life Sciences IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Sai Life Sciences IPO valuation snapshot: P/E 203.82, EPS 2.69, P/B 10.18, RoNW 8.13%, and market cap N/A.
To apply for Sai Life Sciences IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Sai Life Sciences IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Sai Life Sciences IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Sai Life Sciences IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Sai Life Sciences IPO allotment status on IPO Ji for quick and easy access.